About
Copper Histidinate
Areas of Focus
Categories
Small Molecule PharmaceuticalSoutheastern U.S.
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
143
By Phase
PHASE3: 1
By Status
UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT04337684Lead Sponsor
Long Term Follow-up on Menkes Disease Patients
N/AUnknown
50 participants
Started: Dec 1, 2019 · Completed: Dec 31, 2023
NCT00811785Lead Sponsor
Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency
PHASE3Completed
93 participants
Started: Feb 27, 2009 · Completed: Aug 28, 2020
Funding History (1)
D
Oct 27, 2021
Locations (1)
Headquarters
Bay Harbor Islands, FL, United States
Map
Loading map...